Skip to main content
    S

    Semler Scientific Inc (SMLR)

    Official site

    MEDICAL DEVICES

    $20.33
    +0.00 (+0.00%)

    Last updated: Jan 16, 2026 at 4:00 PM ET

    Semler Scientific Inc (SMLR) Financials: Revenue, Profit and Cash Flow

    Updated Nov 3, 2025. Financial statements from company filings, amounts in US dollars.

    Semler Scientific reported revenue of $56.29M for the fiscal year ended Dec 31, 2024, down 17.4% from the year before. That year, net income was $40.90M with a net margin of 72.7%, operating cash flow was $24.41M and free cash flow was $24.36M. The quarter ended Sep 30, 2025 had revenue of $7.49M and net income of $16.90M.

    Revenue and Margins

    The operating margin was 37.2% in the fiscal year ended Dec 2024. Over the 9 years to Dec 2024, revenue grew from $7.00M, a compound annual rate of 26.1%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2024$56.29M-17.4%91.5%37.2%72.7%
    Dec 2023$68.18M+20.3%89.8%32.6%30.2%
    Dec 2022$56.69M+6.9%92.5%30.3%25.3%
    Dec 2021$53.03M+37.4%88.5%36.7%32.5%
    Dec 2020$38.60M+17.8%91.3%41.3%36.3%
    Dec 2019$32.77M+52.5%88.8%32.7%46.0%
    Dec 2018$21.49M+72.6%87.4%24.9%23.3%
    Dec 2017$12.45M+67.5%79.5%-6.9%-12.1%
    Dec 2016$7.43M+6.2%63.2%-29.0%-34.4%
    Dec 2015$7.00MN/A38.8%-120.3%-121.4%
    Annual, fiscal years ended Dec 2015 to Dec 2024

    Income Statement

    In the fiscal year ended Dec 2024, net income rose 98.7% from the year before. In the quarter ended Sep 2025, net income rose 201.2% from the same quarter a year earlier.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
    Revenue$56.29M$68.18M$56.69M$53.03M$38.60M$32.77M$21.49M$12.45M$7.43M$7.00M
    Cost of revenue$4.76M$6.98M$4.25M$6.12M$3.36M$3.66M$2.70M$2.55M$2.74M$4.28M
    Gross profit$51.53M$61.20M$52.43M$46.91M$35.25M$29.11M$18.79M$9.90M$4.70M$2.72M
    Research and development$4.79M$5.77M$4.81M$3.78M$2.94M$2.48M$2.08M$1.83M$0$0
    Operating income$20.93M$22.26M$17.20M$19.45M$15.96M$10.71M$5.34M-$853.00K-$2.16M-$8.42M
    Net income$40.90M$20.58M$14.32M$17.22M$14.01M$15.08M$5.01M-$1.51M-$2.55M-$8.50M
    EBITDA$46.59MN/A$17.79M$20.07M$17.04M$11.33M$5.86M-$143.00K-$1.53M-$8.04M
    Fiscal years ended Dec 2015 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Revenue$7.49M$8.22M$8.84M$12.41M$13.51M$14.46M$15.90M$15.06M$16.32M$18.61M$18.21M$13.79M
    Gross profit$6.86M$7.48M$7.90M$11.31M$12.36M$13.21M$14.66M$11.67M$15.21M$17.39M$16.94M$12.61M
    Operating income-$5.39M-$2.05M-$31.10M$3.54M$5.07M$5.35M$6.98M$2.52M$6.30M$7.18M$6.26M$3.62M
    Net income$16.90M$66.93M-$64.70M$29.21M$5.61M$11.00K$6.07M$4.22M$5.51M$5.88M$4.97M$3.22M
    Last 12 quarters

    Balance Sheet

    As of Dec 2024, the balance sheet showed $8.82M in cash and equivalents and no debt.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
    Total assets$239.83M$78.06M$62.69M$50.67M$34.64M$18.29M$7.72M$4.24M$3.07M$3.08M
    Current assets$22.69M$65.94M$48.91M$45.54M$26.60M$11.44M$6.24M$2.88M$1.59M$1.75M
    Cash and equivalents$8.82M$57.20M$23.01M$37.32M$22.08M$7.74M$3.28M$1.46M$622.00K$405.00K
    Total liabilities$9.08M$6.27M$7.02M$5.13M$4.85M$5.21M$3.52M$6.82M$5.99M$4.15M
    Short-term debt$0$90.00K$85.00K$80.00K$2.80MN/AN/A$1.02M$81.00KN/A
    Long-term debt$0N/AN/AN/AN/AN/A$11.00K$26.00K$938.00KN/A
    Shareholder equity$230.75M$71.80M$55.68M$45.55M$29.79M$13.07M$4.20M-$2.58M-$2.92M-$1.07M
    Fiscal years ended Dec 2015 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total assets$596.68M$522.60M$293.44M$239.83M$92.19M$84.79M$83.86M$78.06M$79.44M$75.46M$70.26M$62.69M
    Total liabilities$136.93M$139.19M$131.76M$9.08M$6.84M$6.39M$5.95M$6.27M$8.67M$10.20M$9.06M$7.02M
    Cash and equivalents$10.18M$13.48M$9.74M$8.82M$6.57M$7.33M$62.75M$57.20M$37.50M$39.49M$5.30M$23.01M
    Shareholder equity$459.75M$383.41M$161.68M$230.75M$85.36M$78.40M$77.91M$71.80M$70.77M$65.26M$61.20M$55.68M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2024, free cash flow was 99.8% of operating cash flow. Share repurchases came to 12.3% of it.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
    Operating cash flow$24.41M$21.33M$17.46M$16.06M$15.11M$12.73M$4.70M$621.00K-$1.80M-$4.13M
    Capital expenditures$51.00K$345.00K$2.16M$825.00K$758.00K$1.70M$844.00K$971.00K$814.00K$1.10M
    Free cash flow$24.36M$20.98M$15.30M$15.23M$14.36M$11.03M$3.85M-$350.00K-$2.62M-$5.24M
    Share repurchases$3.00M$1.95M$4.99M$0N/A$6.63MN/AN/AN/AN/A
    Investing cash flow-$189.98M$18.40M-$26.84M-$825.00K-$1.01M-$1.70M-$843.00K-$968.00K-$814.00K$996.00K
    Financing cash flow$117.19M-$5.41M-$4.94M$13.00K$230.00K-$6.57M-$2.03M$1.18M$2.83M-$612.00K
    Fiscal years ended Dec 2015 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Operating cash flow-$32.95M$514.00K-$1.91M$7.43M$6.42M$4.93M$5.62M$4.44M$4.83M$11.20M$861.00K$1.71M
    Capital expenditures$11.00K$149.67M$0$32.00K$8.44M$44.00K$4.00K$738.00K$149.00K$295.00K$639.00K$811.00K
    Free cash flow-$32.96M-$149.15M-$1.91M$7.39M-$2.01M$4.89M$5.62M$3.70M$4.68M$10.90M$222.00K$899.00K
    Last 12 quarters

    Frequently Asked Questions About SMLR

    What is Semler Scientific's annual revenue?

    Semler Scientific reported revenue of $56.29M for the fiscal year ended Dec 31, 2024.

    How fast is Semler Scientific's revenue growing?

    Revenue was down 17.4% for the fiscal year ended Dec 31, 2024 compared with the year before. The compound annual revenue growth rate over 3 years was 2.0%.

    Is Semler Scientific profitable?

    Yes. Semler Scientific reported net income of $40.90M for the fiscal year ended Dec 31, 2024, with a net margin of 72.7%.

    How much free cash flow does SMLR generate?

    For the fiscal year ended Dec 31, 2024, operating cash flow of $24.41M minus capital expenditures of $51.00K produced free cash flow of $24.36M.

    How much debt does Semler Scientific have?

    The balance sheet dated Dec 31, 2024 reported long-term debt of $0, short-term debt of $0 and cash and equivalents of $8.82M.